tiprankstipranks
Veradermics, Incorporated (MANE)
NYSE:MANE
US Market
Want to see MANE full AI Analyst Report?

Veradermics, Incorporated (MANE) Blogger Opinions & Sentiment

46 Followers

Blogger Sentiment

Bullish: 66.67%
Sector Average
Bullish
MANE Blogger sentiment is based on 3 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the General sector.

Blogger Article Distribution

ArticleDistribution
66% GuruFocus
34% Investing
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

MONTANOVA CAPITAL, LLC Trims Veradermics Inc (MANE) Stake in Recent 13DG Filing
GuruFocus
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

B.Riley initiates Veradermics stock coverage with Buy on hair loss drug
Investing
Ero Copper: A Copper Growth Story Trading at a Discount
GuruFocus
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of MANE?
Seeking Alpha’s Renato Neves has a Bullish Sentiment.
    What do Motley Fool contributors think of MANE?
    Currently there's no blogger sentiment for MANE.
    What Is MANE’s Blogger Sentiment?
    MANE’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for MANE?
      The most recent blogger prediction for MANE was made by GuruFocus News, who was Bearish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the General sector
          PURRHyperliquid Strategies Inc
          ASSTStrive Inc
          ECGEverus Construction Group, Inc.
          CCXIChurchill Capital Corp. XI Class A
          IBRXImmunityBio